Subcutaneous Versus Transvenous Implantable Defibrillator Therapy

Subcutaneous Versus Transvenous Implantable Defibrillator Therapy

Fro of D Re Hu an Me rec Me rel Ma OBJECTIVES This study aims to conduct a meta-analysis comparing efficacy and safety outcomes between subcutaneous implantable cardioverter-defibrillator (S-ICD) and transvenous implantable cardioverter-defibrillator

Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.

BACKGROUND Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival in patients at risk for sudden cardiac death, but complications remain an important drawback. The subcutaneous ICD (S-ICD) was developed to overcome lead-related complications. Comparison of clinical outcomes of both device types in previous studies was hampered by dissimilar patient characteristics. OBJ...

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator

Introduction The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a safe and effective treatment for prevention of sudden cardiac death. It is typically not used in patients who require additional therapies conferred by transvenous implantable cardioverter-defibrillator (TV-ICD) systems, such as bradycardia pacing or antitachycardia pacing (ATP) for ventricular tachycardia (VT). D...

Subcutaneous implantable cardioverter-defibrillator.

or nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead. Traditional ICDs are implanted under the skin with the generator positioned beneath the collar bone. The defibrilla-tion lead is inserte...

Subcutaneous implantable cardioverter defibrillator.